Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO AI and Digital Oncology 2025 | Advances in wearable digital technologies for oncology monitoring

Rosalind Picard, ScD, MIT Media Lab, Cambridge, MA, discusses recent advancements in wearable digital technologies in oncology, which have evolved to provide continuous, raw, and clinically validated data, and are now being utilized in numerous clinical trials to monitor patients. Wearables can be used to collect data as endpoints in clinical trials and to monitor various chronic conditions, such as changes in gait, tremor, pain levels, sleep patterns, and seizure occurrences. This interview took place at the 2025 European Society for Medical Oncology (ESMO) AI & Digital Oncology Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yes, wearables have taken off in terms of not only comfort to wear 24/7 for not just a day, but for months and years of continuous data, but also they have moved from getting snippets of consumer data to giving continuous raw validated clinical-quality data, validated through lots of patient studies and validated through regulatory boards such as the FDA. So there are already wearables being used in lots of clinical trials to monitor patients...

Yes, wearables have taken off in terms of not only comfort to wear 24/7 for not just a day, but for months and years of continuous data, but also they have moved from getting snippets of consumer data to giving continuous raw validated clinical-quality data, validated through lots of patient studies and validated through regulatory boards such as the FDA. So there are already wearables being used in lots of clinical trials to monitor patients. They are used today both to collect data as endpoints in clinical trials and also to monitor follow-on situations that are chronic. So for example, they are used today to monitor for changes in gait and steps. They’re used today to monitor for changes in tremor. They’re used to monitor for changes in pain level. They’re used to monitor for changes, say, a treatment that’s affecting sleep. And they also are used to monitor seizures, the occurrence of seizures, about half of which go unreported by people. So getting more accurate counts of when events like that are happening.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...